The role of ferritin in liver disease assessment

QR Code

The role of ferritin in liver disease assessment

Background. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 of patients with nonalcoholic fatty liver disease (NAFLD), manifestations of hyperferritinemia are revealed. Increased ferritin level indicates the severity of the disease course and affects the prognosis.O...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2023-11-01
Series:	Фармакоэкономика
Subjects:	nonalcoholic fatty liver disease nafld ferritin iron metabolism disorder systemic inflammation insulin resistance human placenta hydrolysate peptides laennec
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/895
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis
by: M. Imawari, et al.
Published: (2023-11-01)

Study of the effectiveness of the drug Laennek in case of liver damage by palm oil in rats
by: T. E. Bogacheva, et al.
Published: (2024-01-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01)

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
by: K. A. Andreev, et al.
Published: (2022-01-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India
by: Sounak Sinha, et al.
Published: (2025-06-01)

Association between triglyceride–glucose index and liver enzymes in adults with metabolic syndrome: a retrospective cross-sectional study
by: Raju Rana, et al.
Published: (2025-12-01)

Excessive Iron Induces Macrophage Dysfunction in the Liver, Causing Adverse Pregnancy Outcomes in Mice
by: Sayaka Shimazaki, et al.
Published: (2025-06-01)

Non-pharmacological methods of treatment and rehabilitation of patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report
by: Alvin Nursalim, et al.
Published: (2017-02-01)

The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-Based Case Report
by: Alvin Nursalim, et al.
Published: (2017-02-01)

PSpa Treatment of Nonalcoholic Fatty Liver Disease in Patients with Metabolic Syndrome with Drinking Mineral Water of Essentuki Type Applications
by: T. E. Fedorova, et al.
Published: (2012-12-01)

Urinary Ferritin as an Early Indicator of Tubular Injury in Diabetic Kidney Disease: Insights from NHANES and Clinical Cohorts
by: Huang B, et al.
Published: (2025-07-01)

Metabolic effects of ursodeoxycholic acid in patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov
Published: (2024-04-01)

LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW
by: Yu. L. Korsakova, et al.
Published: (2017-09-01)

Association of Hepatic Fibrosis Measured by Transient Elastography with Ferritin Level of Patients with Transfusion Dependent Thalassemia in Iraq
by: zainab Gataa, et al.
Published: (2025-06-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders
by: O. A. Gromova, et al.
Published: (2021-02-01)

Placenta peptides: antibacterial effects
by: I. Yu. Torshin, et al.
Published: (2024-01-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Serum ferritin level in patients of allergic rhinitis
by: Souvagini Acharya, et al.
Published: (2025-01-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

The clinical signiﬁcance of adiponectimics in formation of aﬀected target-organs during the metabolic syndrome associated with nonalcoholic fatty liver disease
by: E. A. Saginova, et al.
Published: (2011-03-01)

Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
by: Chi-Kuei Hsu, et al.
Published: (2025-07-01)

Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders
by: O. A. Gromova, et al.
Published: (2024-02-01)

Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
by: Minkwan Kim, et al.
Published: (2025-07-01)

Ultrasound Score of Liver Steatosis Severity in the Diagnosis of Peripheral Arterial Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: A. S. Kuznetsova, et al.
Published: (2023-06-01)

Prevalence of Helicobacter pylori infected in the Kirkuk native population and aassociated with serum ferritin and Iron levels/Iraq
by: Nadia M. Mohammad, et al.
Published: (2019-04-01)

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy
by: Siwen Shen, et al.
Published: (2025-07-01)

Systematic analysis of the pharmacology of standardized extracts of human placenta
by: T. E. Bogacheva, et al.
Published: (2024-01-01)

Iron Deficiency in Depressive Disorders: A Review of Mechanisms, Clinical Relevance, and Treatment Perspectives
by: Michał Wycik, et al.
Published: (2025-07-01)

Serum ferritin and risk of stroke: a meta-analysis of observation studies
by: Wen Zheng, et al.
Published: (2025-07-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

A Scientometric Assessment of MAFLD in Children and Adolescents from 2007–2024
by: Raju Vaishya, et al.
Published: (2025-07-01)

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
by: V. T. Ivashkin, et al.
Published: (2025-03-01)

The action of Poria cocos polysaccharides against non-alcoholic fatty liver disease: A preliminary study
by: Rui Zhou, et al.
Published: (2025-12-01)